Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: Monophenylboronic acids

Paul C. Trippier, Christopher McGuigan, Jan Balzarini

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: The development of carbohydrate-binding agents as novel therapeutics for the inhibition of highly glycosylated enveloped viruses has generated much attention in recent literature. Possessing a potential dual mode of action by inhibiting virus entry and exposing the virion to neutralization by the host immune system upon the deletion of envelope glycans under drug pressure, these substances might provide a new direction in antiviral treatment. Phenylboronic acids are widely known to bind the cis-diol functionality of carbohydrate structures, thereby identifying themselves as potential lead structures. To date, few details have been disclosed of the structure-activity relationship of these substances in correlation to their antiviral activity. Methods: In this study, a compound library of a diverse range of ortho-, meta- and para- ring-substituted monophenylboronic acids and glutamine phenylboronic acid analogues was prepared, characterized and evaluated to probe antiviral activity versus a broad range of (enveloped) viruses. Results: The compounds described herein lack antiviral activity. They also did not show measurable binding to HIV type-1 (HIV-1) gp120, using surface plasmon resonance technology. However, of note is the general lack of toxicity, which suggests that further investigation of the compounds as potential therapeutics is needed. Conclusions: The monophenylboronic acids tested exhibited no antiviral activity as potential carbohydrate binders versus a broad range of enveloped and non-enveloped viruses. The compounds tested did not bind HIV-1 gp120, possibly because of their small size and lack of multivalency.

Original languageEnglish (US)
Pages (from-to)249-257
Number of pages9
JournalAntiviral Chemistry and Chemotherapy
Volume20
Issue number6
DOIs
StatePublished - Sep 27 2010

Fingerprint

Antiviral Agents
Carbohydrates
Acids
Viruses
HIV-1
Therapeutics
Virus Internalization
Surface Plasmon Resonance
Structure-Activity Relationship
Glutamine
Virion
Libraries
Polysaccharides
Immune System
benzeneboronic acid
Technology
Pressure
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Virology

Cite this

Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics : Monophenylboronic acids. / Trippier, Paul C.; McGuigan, Christopher; Balzarini, Jan.

In: Antiviral Chemistry and Chemotherapy, Vol. 20, No. 6, 27.09.2010, p. 249-257.

Research output: Contribution to journalArticle

@article{aeb81766e4824d9e85bfadfb5a5d3e97,
title = "Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: Monophenylboronic acids",
abstract = "Background: The development of carbohydrate-binding agents as novel therapeutics for the inhibition of highly glycosylated enveloped viruses has generated much attention in recent literature. Possessing a potential dual mode of action by inhibiting virus entry and exposing the virion to neutralization by the host immune system upon the deletion of envelope glycans under drug pressure, these substances might provide a new direction in antiviral treatment. Phenylboronic acids are widely known to bind the cis-diol functionality of carbohydrate structures, thereby identifying themselves as potential lead structures. To date, few details have been disclosed of the structure-activity relationship of these substances in correlation to their antiviral activity. Methods: In this study, a compound library of a diverse range of ortho-, meta- and para- ring-substituted monophenylboronic acids and glutamine phenylboronic acid analogues was prepared, characterized and evaluated to probe antiviral activity versus a broad range of (enveloped) viruses. Results: The compounds described herein lack antiviral activity. They also did not show measurable binding to HIV type-1 (HIV-1) gp120, using surface plasmon resonance technology. However, of note is the general lack of toxicity, which suggests that further investigation of the compounds as potential therapeutics is needed. Conclusions: The monophenylboronic acids tested exhibited no antiviral activity as potential carbohydrate binders versus a broad range of enveloped and non-enveloped viruses. The compounds tested did not bind HIV-1 gp120, possibly because of their small size and lack of multivalency.",
author = "Trippier, {Paul C.} and Christopher McGuigan and Jan Balzarini",
year = "2010",
month = "9",
day = "27",
doi = "10.3851/IMP1632",
language = "English (US)",
volume = "20",
pages = "249--257",
journal = "Antiviral Chemistry and Chemotherapy",
issn = "0956-3202",
publisher = "International Medical Press Ltd",
number = "6",

}

TY - JOUR

T1 - Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics

T2 - Monophenylboronic acids

AU - Trippier, Paul C.

AU - McGuigan, Christopher

AU - Balzarini, Jan

PY - 2010/9/27

Y1 - 2010/9/27

N2 - Background: The development of carbohydrate-binding agents as novel therapeutics for the inhibition of highly glycosylated enveloped viruses has generated much attention in recent literature. Possessing a potential dual mode of action by inhibiting virus entry and exposing the virion to neutralization by the host immune system upon the deletion of envelope glycans under drug pressure, these substances might provide a new direction in antiviral treatment. Phenylboronic acids are widely known to bind the cis-diol functionality of carbohydrate structures, thereby identifying themselves as potential lead structures. To date, few details have been disclosed of the structure-activity relationship of these substances in correlation to their antiviral activity. Methods: In this study, a compound library of a diverse range of ortho-, meta- and para- ring-substituted monophenylboronic acids and glutamine phenylboronic acid analogues was prepared, characterized and evaluated to probe antiviral activity versus a broad range of (enveloped) viruses. Results: The compounds described herein lack antiviral activity. They also did not show measurable binding to HIV type-1 (HIV-1) gp120, using surface plasmon resonance technology. However, of note is the general lack of toxicity, which suggests that further investigation of the compounds as potential therapeutics is needed. Conclusions: The monophenylboronic acids tested exhibited no antiviral activity as potential carbohydrate binders versus a broad range of enveloped and non-enveloped viruses. The compounds tested did not bind HIV-1 gp120, possibly because of their small size and lack of multivalency.

AB - Background: The development of carbohydrate-binding agents as novel therapeutics for the inhibition of highly glycosylated enveloped viruses has generated much attention in recent literature. Possessing a potential dual mode of action by inhibiting virus entry and exposing the virion to neutralization by the host immune system upon the deletion of envelope glycans under drug pressure, these substances might provide a new direction in antiviral treatment. Phenylboronic acids are widely known to bind the cis-diol functionality of carbohydrate structures, thereby identifying themselves as potential lead structures. To date, few details have been disclosed of the structure-activity relationship of these substances in correlation to their antiviral activity. Methods: In this study, a compound library of a diverse range of ortho-, meta- and para- ring-substituted monophenylboronic acids and glutamine phenylboronic acid analogues was prepared, characterized and evaluated to probe antiviral activity versus a broad range of (enveloped) viruses. Results: The compounds described herein lack antiviral activity. They also did not show measurable binding to HIV type-1 (HIV-1) gp120, using surface plasmon resonance technology. However, of note is the general lack of toxicity, which suggests that further investigation of the compounds as potential therapeutics is needed. Conclusions: The monophenylboronic acids tested exhibited no antiviral activity as potential carbohydrate binders versus a broad range of enveloped and non-enveloped viruses. The compounds tested did not bind HIV-1 gp120, possibly because of their small size and lack of multivalency.

UR - http://www.scopus.com/inward/record.url?scp=77956915133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956915133&partnerID=8YFLogxK

U2 - 10.3851/IMP1632

DO - 10.3851/IMP1632

M3 - Article

C2 - 20710065

AN - SCOPUS:77956915133

VL - 20

SP - 249

EP - 257

JO - Antiviral Chemistry and Chemotherapy

JF - Antiviral Chemistry and Chemotherapy

SN - 0956-3202

IS - 6

ER -